Last edition
News about Biotechnology
Fujifilm Opens GBP 400 Million UK Biomanufacturing Expansion
Backed by an investment of approximately GBP 400 million from Fujifilm Corporation, the development includes the launch of what the company describes as the UK’s largest single-use biopharmaceutical contract development and manufacturing facility.
Biotechnology | 12/02/2026 | By Darshana | 189
NPPA Directs Drugmakers to Revise MRPs After 2026 Duty Exemptions
The National Pharmaceutical Pricing Authority (NPPA) has directed drug manufacturers to revise the maximum retail prices (MRP) of medicines that received customs duty exemptions under the Union Budget 2026.
Biotechnology | 12/02/2026 | By Darshana | 403
Chugai Exercises Option for AraLinQ Technology in USD 780 Million ADC Collaboration
Chugai Pharmaceutical Co., Ltd. has exercised its option to license Araris Biotech AG’s proprietary AraLinQ linker-payload platform, deepening an existing research collaboration aimed at developing next-generation antibody-drug conjugates (ADCs).
Biotechnology | 11/02/2026 | By Darshana | 248
Lilly’s acquisition of Orna Therapeutics aims to accelerate development of in vivo CAR-T therapies powered by engineered circular RNA and advanced lipid nanoparticle delivery platforms.
Biotechnology | 10/02/2026 | By News Bureau | 270
This collaboration with Frontier Space provides an opportunity for Azenta to demonstrate how its sample management technologies perform in demanding research environments, helping extend use of its high-precision consumables into new research settings and next-generation workflows, further reinforcing the company's leadership in sample integrity.
Biotechnology | 10/02/2026 | By News Bureau | 135
FUJIFILM Biotechnologies Enhances UK Manufacturing with Advanced Downstream Purification System
FUJIFILM Biotechnologies has announced plans to deploy its proprietary downstream purification system at its manufacturing facility in the United Kingdom, aiming to enhance production efficiency and expand biopharmaceutical processing capabilities.
Biotechnology | 09/02/2026 | By Darshana | 160
Slingshot Backs New Precision Oncology Venture from Crick Research
Slingshot Therapeutics, Syncona’s accelerator platform for advancing early-stage drug discovery programmes, has launched ALTx Therapeutics with an initial £12.55 million funding commitment from Syncona, the Francis Crick Institute, and Cancer Research Horizons.
Biotechnology | 07/02/2026 | By Darshana | 212
Japan Patent Boosts Marvel's Neurology Pipeline for MB-204
Marvel Biosciences Corporation, through its subsidiary Marvel Biotechnology Inc., has secured a key intellectual property milestone after the Japan Patent Office granted a patent covering its lead therapeutic candidate, MB-204.
Biotechnology | 05/02/2026 | By Darshana | 175
UK Industry Body Finds Sanofi in Breach Over RSV Therapy Claims Against Pfizer
A UK pharmaceutical industry watchdog has ruled that Sanofi breached the country’s code of practice by making misleading claims about its respiratory syncytial virus (RSV) therapy in comparison with a rival product from Pfizer.
Biotechnology | 04/02/2026 | By Darshana | 242
Tenacia and Golden Age Health Partner to Commercialise Ztalmy for CDKL5 Deficiency Disorder in China
Tenacia Biopharmaceuticals has granted Golden Age Health exclusive rights to commercialise Ztalmy, the first approved therapy for CDKL5 deficiency disorder, in Mainland China.
Biotechnology | 03/02/2026 | By News Bureau | 298
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy